Glaucoma
Conditions
Brief summary
The purpose of this observational study is to collect over time a series of data in patients with glaucoma in order to evaluate different approaches in defining the progression of this pathology. These data will be collected in repeated visits over a 36-months follow-up period. At each visit, the COMPASS fundus perimeter and the Humphrey Field Analyzer (HFA) perimeter will be used to assess retinal functionality; an Optical Coherence Tomography (OCT) examination will also be performed to evaluate and obtain clinical information about the structure of the retina.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Glaucomatous optic nerve head in both eyes; * Age between 40 and 90 years; * Best Corrected Visual Acuity ≤ 0.3 \[logMar\]; * Spherical refraction between -6D and +6D; * Astigmatism between -2D and +2D.
Exclusion criteria
* Any ocular surgery, except for: uncomplicated cataract surgery and/or glaucoma surgery in both eyes performed within 6 months before enrollment; * Any ocular pathology that can affect visual field other than glaucoma; * Use of any drug that can interfere with the correct execution of perimetry or that would produce visual field loss; * Inability to obtain reliable perimetric examinations; * Patients with advanced glaucoma for whom, according to the clinician, a 24-2 grid is not advisable to correctly monitor the patient.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Equivalence between Compass and HFA in terms of estimation of the global progression rate (MD progression slope). | 1 visit every 4 months (10 visits total), up to 3 years | Equivalence will be defined as the 95% confidence Intervals of the mean difference between the slopes estimated with the two devices being within ± 0.1 dB/year |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Difference in time to identify progression between Compass and HFA using an event analysis | 1 visit every 4 months (10 visits total), up to 3 years | Time of first detectable change \[years\] |
| Quantification of the effect of the integration of the rate of progression of structural metrics into the calculation of the rate of progression of the MD | 1 visit every 4 months (10 visits total), up to 3 years | Quantification of the effect of the integration of the rate of progression of structural metrics (mainly the retinal nerve fiber layer thickness, microns/year) into the calculation of the rate of progression of the MD. This effect will be quantified as the improvement in the equivalence metric defined for Outcome 1 The integration of structural OCT RNFL thickness information into progression analysis will be done using a Bayesian Linear Regression approach as suggested by Russel at al.\[\*\] \[\*\] R.A. Russel at al.; Improved Estimates of Visual Field Progression Using Bayesian Linear Regression to Integrate Structural Information in Patients with Ocular Hypertension; IOVS May 2012; 53(6): 2760-2769. |
Countries
Italy